An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With aTypical Hemolytic-Uremic Syndrome (aHUS Registry)

Trial Profile

An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With aTypical Hemolytic-Uremic Syndrome (aHUS Registry)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs Eculizumab (Primary)
  • Indications Haemolytic uraemic syndrome
  • Focus Adverse reactions
  • Sponsors Alexion Pharmaceuticals
  • Most Recent Events

    • 17 Nov 2016 Data from patients with aHUS who were treated with eculizumab and underwent kidney transplant (n=147) published in the Media Release
    • 17 Nov 2016 Data from patients with aHUS who were treated with eculizumab and underwent kidney transplant (n=147) were presented at the 2016 annual meeting of the American Society of Nephrology (ASN), according to an Alexion Pharmaceuticals Inc. media release.
    • 09 Dec 2015 Last checked against ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top